Delivery Order SPE2DE24D0013-SPE2D626F856R
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $4,198.65 firm fixed-price delivery order (Contract No. 4569971781) from the Defense Logistics Agency Medical Supply Chain on November 10, 2025, for respiratory pathogen diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order is scheduled for completion by November 18, 2025, and carries no set-aside designation. The award...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a delivery order valued at $5,440 on December 1, 2025, from the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, has been awarded a delivery order valued at $16,381 by the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. The delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, utilizes a firm fixed-price structure with no set-aside designation. This award represents a continuation of...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,992 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, on November 5, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus testing. The contract carries no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a $9,868.32 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, for respiratory diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The delivery order, which carries an ultimate completion date of November 13, 2025, represents a near-term procurement of molecular diagnostic reagents and test kits utilizing Cepheid's GeneXpert diagnostic platform. No set-aside...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The Defense Logistics Agency Medical Supply Chain awarded a $23,188 firm fixed-price delivery order to Cepheid Inc. on December 3, 2025, for SARS-CoV-2, influenza, and RSV diagnostic testing supplies. The order, which is expected to be completed by December 17, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the federal...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F856RDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $21,888.40 firm fixed-price delivery order on December 5, 2025, for COVID-19/Influenza/RSV diagnostic supplies, with completion targeted for December 12, 2025. This delivery order, issued without set-aside designation, represents procurement under the agency's medical supply chain operations and aligns with Cepheid's established role as a primary federal supplier of molecular diagnostic testing solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid specializes in advanced molecular diagnostic systems and reagents, with particular expertise in rapid infectious disease detection through its GeneXpert platform. The company maintains an extensive federal customer base spanning the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, delivering diagnostic equipment, test kits, reagents, and maintenance services. This delivery order for respiratory pathogen testing supplies supports the Defense Logistics Agency's mission to ensure medical readiness across the military healthcare system by providing critical diagnostic capabilities for common infectious disease threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 12/4/25 |